Related Experiment Video
Updated: Mar 14, 2026
Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
Type 4 cardiorenal syndrome
Ana Luísa Pinheiro da Silva1, Manuel Joaquim Vaz da Silva2
1Faculty of Medicine of Porto University, Porto, Portugal.
Insights
Type 4 cardiorenal syndrome (CRS) involves complex, multifactorial mechanisms, with oxidative stress playing a key role. Understanding these factors is crucial for managing this growing public health concern in chronic kidney disease patients.
Area of Science:
- Nephrology
- Cardiology
- Pathophysiology
Background:
- Cardiorenal syndrome (CRS) classification was proposed by the Acute Dialysis Quality Initiative.
- Type 4 CRS pathophysiology remains incompletely understood but is likely multifactorial.
- Oxidative stress is increasingly recognized as a significant factor in Type 4 CRS development and progression.
Purpose of the Study:
- To review the definition, epidemiology, diagnosis, prognosis, biomarkers, and management of Type 4 CRS.
- To highlight the pathophysiological mechanisms and risk factors involved in Type 4 CRS.
- To underscore the need for further research into Type 4 CRS given its complexity and poor prognosis.
Main Methods:
- Literature review focusing on cardiorenal syndrome (CRS) and Type 4 CRS.
- Analysis of existing evidence regarding oxidative stress and chronic kidney disease (CKD) in cardiac dysfunction.
- Synthesis of information on risk factors, pathophysiology, and therapeutic targets for Type 4 CRS.
Main Results:
- Type 4 CRS is a significant public health issue with increasing incidence and poor prognosis.
- Patients with chronic kidney disease (CKD) are highly susceptible to cardiac dysfunction.
- Traditional and CKD-specific risk factors contribute to Type 4 CRS, with oxidative stress being a central mechanism.
Conclusions:
- Further elucidation of Type 4 CRS pathophysiology is essential for developing targeted interventions.
- Despite advancements, specific therapies for Type 4 CRS are still lacking.
- Understanding the mechanisms of Type 4 CRS may reveal potential targets for future treatments.
Abstract:
The Acute Dialysis Quality Initiative consensus conference proposed a classification of cardiorenal syndrome (CRS), aiming for a better delineation of each subtype. Although the exact pathophysiology of type 4 CRS is not completely understood, the mechanisms involved are probably multifactorial. There is growing evidence that oxidative stress is a major connector in the development and progression of type 4 CRS. Giving its complexity, poor prognosis and increasing incidence, type 4 CRS is becoming a significant public health problem. Patients with chronic kidney disease are particularly predisposed to cardiac dysfunction, due to the high prevalence of traditional cardiovascular risk factors in this population, but the contribution of risk factors specific to chronic kidney disease should also be taken into account. Much remains to be elucidated about type 4 CRS: despite progress over the last decade, there are still significant questions regarding its pathophysiology and there is as yet no specific therapy. A better understanding of the mechanisms involved may provide potential targets for intervention. The present review will provide a brief description of the definition, epidemiology, diagnosis, prognosis, biomarkers and management strategies of type 4 CRS, and the pathophysiological mechanisms and risk factors presumably involved in its development will be particularly highlighted.
Related Concept Videos
01:29Acute Kidney Injury II: Pathophysiology
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
01:30Continuous Renal Replacement Therapy
01:29Heart Failure II: Pathophysiology
01:28Cardiac Catheterization I: Pre-Procedure Overview
01:20Acute Kidney Injury V: Interprofessional Care